SRF has been shown to move into the nucleus in association with the transcriptional cofactor megakaryoblastic leukemia 1 (MLK1), where together they form a protein complex with GLI1 that enhances the transcription of HH pathway target genes and drug-resistant tumor growth [194]. The gene discussed is GLI1; the disease is neoplasm.